Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
Vancouver, British Columbia
Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.
On-site · Vancouver
Develop and execute IT infrastructure strategies to support the company's transition to a clinical stage biotech. Oversee core software systems, enforce cybersecurity postures, and drive the safe adoption of AI for operational efficiency.